# Efficacy of Nebulized Lidocaine, Salbutamol, and Beclomethasone Plus Salbutamol in the Covid-19 Patients With ARDS on Non-invasive Ventilation; Randomized Control Trial

> **NCT04979923** · PHASE1 · UNKNOWN · sponsor: **Sheikh Zayed Medical College** · enrollment: 81 (estimated)

## Conditions studied

- COVID-19 Acute Respiratory Distress Syndrome

## Interventions

- **DRUG:** Lidocaine

## Key facts

- **NCT ID:** NCT04979923
- **Lead sponsor:** Sheikh Zayed Medical College
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-01
- **Primary completion:** 2021-07-31
- **Final completion:** 2021-08
- **Target enrollment:** 81 (ESTIMATED)
- **Last updated:** 2021-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04979923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04979923, "Efficacy of Nebulized Lidocaine, Salbutamol, and Beclomethasone Plus Salbutamol in the Covid-19 Patients With ARDS on Non-invasive Ventilation; Randomized Control Trial". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04979923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*